Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines

Overview of attention for article published in Targeted Oncology, February 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 297 followers.

Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines https://t.co/QDW5mqpPtc

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.